8-K current report · filed Jul 2, 2026

Tenaya Therapeutics Inc (TNYA) 8-K Current Report: July 2, 2026

Item 1.02TNYA overview

Short answer

Tenaya Therapeutics Inc (TNYA) filed an 8-K current report with the SEC on July 2, 2026 reporting Item 1.02 (Termination of a Material Definitive Agreement). Union City GMMC lease ends August 31, 2026, versus original July 2031 expiration.

Tenaya Therapeutics Inc 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.02 · Termination of a Material Definitive Agreement

  • Union City GMMC lease ends August 31, 2026, versus original July 2031 expiration
  • Cost reduction from decommissioned 94,046-square-foot manufacturing facility
  • Termination consideration: forfeiture of $1.75 million security deposit plus approximately $294,200 fee
  • TN-201 and TN-401 trials supported by available inventory, reducing near-term manufacturing needs
  • AAV manufacturing process planned for transfer to a global contract manufacturer for later-stage development or commercialization

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Tenaya Therapeutics Inc 8-K filings

Get the next TNYA 8-K as it lands

Follow TNYA for push alerts, or ask the research agent what this filing means.